Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIAMOND: Patiromer for management of hyperkalemia in heart failure patients on RAAS inhibitors
2018-005030-38Phase 3Completed
- Sponsor
- Vifor Pharma
- Start
- Jun 2019
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hyperkalemia and heart failure (HF) comparing Patiromer arm with Placebo arm (2 arms). Primary endpoint: Change in serum potassium from baseline. Started Jun 2019; status: completed.
02
Drugs
patiromer
03
Conditions
hyperkalemiaheart failure (HF)
Beyond the preview
Go deeper on 2018-005030-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-005030-38.